Jian Xiang
Soochow University (Suzhou)
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jian Xiang.
Advanced Materials | 2014
Chao Wang; Ligeng Xu; Chao Liang; Jian Xiang; Rui Peng; Zhuang Liu
Photothermal ablation of primary tumors with single-walled carbon nanotubes is demonstrated to be able to trigger significant adaptive immune responses, which are not observed if tumors are removed by surgical resection. Such a treatment in combination with anti-CTLA-4 antibody therapy is able to prevent the development of tumor metastasis, which is a major cause of cancer death.
ACS Nano | 2015
Jian Xiang; Ligeng Xu; Hua Gong; Wenwen Zhu; Chao Wang; Jun Xu; Liangzhu Feng; Liang Cheng; Rui Peng; Zhuang Liu
A dendritic cell (DC) vaccine, which is based on efficient antigen delivery into DCs and migration of antigen-pulsed DCs to draining lymph nodes after vaccination, is an effective strategy in initiating CD8(+) T cell immunity for immunotherapy. Herein, antigen-loaded upconversion nanoparticles (UCNPs) are used to label and stimulate DCs, which could be precisely tracked after being injected into animals and induce an antigen-specific immune response. It is discovered that a model antigen, ovalbumin (OVA), could be adsorbed on the surface of dual-polymer-coated UCNPs via electrostatic interaction, forming nanoparticle-antigen complexes, which are efficiently engulfed by DCs and induce DC maturation and cytokine release. Highly sensitive in vivo upconversion luminescence (UCL) imaging of nanoparticle-labeled DCs is successfully carried out, observing the homing of DCs to draining lymph nodes after injection. In addition, strong antigen-specific immune responses including enhanced T cell proliferation, interferon gamma (IFN-γ) production, and cytotoxic T lymphocyte (CTL)-mediated responses are induced by a nanoparticle-pulsed DC vaccine, which is promising for DC-based immunotherapy potentially against cancer.
Nano Research | 2014
Shuai Fang; Chao Wang; Jian Xiang; Liang Cheng; Xuejiao Song; Ligeng Xu; Rui Peng; Zhuang Liu
Detection of circulating tumor cells (CTCs) plays an important role in cancer diagnosis and prognosis. In this study, aptamer-conjugated upconversion nanoparticles (UCNPs) are used for the first time as nanoprobes to recognize tumor cells, which are then enriched by attaching with magnetic nanoparticles (MNPs) and placing in the presence of a magnetic field. Owing to the autofluorescencefree nature of upconversion luminescence imaging, as well as the use of magnetic separation to further reduce background signals, our technique allows for highly sensitive detection and collection of small numbers of tumor cells spiked into healthy blood samples, and shows promise for CTC detection in medical diagnostics.
Advanced Functional Materials | 2014
Hua Gong; Ziliang Dong; Yumeng Liu; Shengnan Yin; Liang Cheng; Wenyao Xi; Jian Xiang; Kai Liu; Yonggang Li; Zhuang Liu
Advanced Functional Materials | 2013
Hua Gong; Liang Cheng; Jian Xiang; Huan Xu; Liangzhu Feng; Xiaoze Shi; Zhuang Liu
Nano Letters | 2016
Hua Gong; Yu Chao; Jian Xiang; Xiao Han; Guosheng Song; Liangzhu Feng; Jingjing Liu; Guangbao Yang; Qian Chen; Zhuang Liu
Nanoscale | 2016
Ligeng Xu; Jian Xiang; Ye Liu; Jun Xu; Yinchan Luo; Liangzhu Feng; Zhuang Liu; Rui Peng
Chinese Science Bulletin | 2016
Ligeng Xu; Jian Xiang; Rui Peng; Zhuang Liu
Biomaterials | 2016
Yun-Yun Xu; Jian Xiang; He Zhao; Hansi Liang; Jie Huang; Yan Li; Jian Pan; Huiting Zhou; Xueguang Zhang; Jiang Huai Wang; Zhuang Liu; Jian Wang
Nanoscale | 2015
Hua Gong; Jian Xiang; Ligeng Xu; Xuejiao Song; Ziliang Dong; Rui Peng; Zhuang Liu